Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Title: Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
Authors: Jokubaitis, Vilija G; Alroughani, Raed; Altintas, Ayse; Eichau, Sara; Hughes, Stella; Willekens, Barbara; Horakova, Dana; Havrdova, Eva Kubala; Ozakbas, Serkan; Boz, Cavit; Habek, Mario; Kalincik, Tomas; Roos, Izanne; Etemadifar, Masoud; Peterka, Marek; Lechner-Scott, Jeannette; Meca-Lallana, Jose E; Rous, Zuzana; Houskova, Jana; Prat, Alexandre; Girard, Marc; Ampapa, Radek; Buzzard, Katherine; Skibina, Olga; John, Nevin A; Kermode, Allan G; Fabis-Pedrini, Marzena J; Foschi, Matteo; Surcinelli, Andrea; Blanco, Yolanda; Baghbanian, Seyed Mohammad; Gerlach, Oliver; Macdonell, Richard; Pavelek, Zbysek; Stourac, Pavel; McCombe, Pamela; Laureys, Guy; Butzkueven, Helmut; van der Walt, Anneke; Gray, Orla; Vachova, Marta; Libertinova, Jana; Barnett, Michael; Hradilek, Pavel; Duquette, Pierre; Martinkova, Alena; Carroll, William M; Recmanova, Eva; Prevost, Julie; Rath, Louise; Izquierdo, Guillermo; Moghadasi, Abdorreza Naser; Slee, Mark; Maimone, Davide; Oh, Jiwon; Terzi, Murat; Grammond, Pierre; Sanchez-Menoyo, Jose Luis; D’Amico, Emanuele; Ferrando, Beatriz Romero; Yetkin, Mehmet Fatih; Yamout, Bassem; Stetkarova, Ivana; Ramo-Tello, Cristina; de Gans, Koen; Gouider, Riadh; Mrabet, Saloua; Al-Asmi, Abdullah; Karabudak, Rana; Soysal, Aysun; Khoury, Samia J.; Lapointe, Emmanuelle; Cárdenas-Robledo, Simón; Shalaby, Nevin; Spitaleri, Daniele; Guimarães, Joana; Jakob, Gregor Brecl; Hodgkinson, Suzanne; Baghbanian, Mohammad; Turkoglu, Recai; van Pesch, Vincent; Grand’Maison, Francois; Cartechini, Elisabetta; Gomez-Figueroa, Enrique; Massey, Jennifer; Nohara, Chiyoko; Sakurai, Kenzo; Mason, Deborah; Al-Harbi, Talal; Castillo-Triviño, Tamara; Shimizu, Fumitaka; Taylor, Bruce; Hardy, Todd A.; Vucic, Steve; Reddel, Stephen; Ramanathan, Sudarshini; Decoo, Danny; de Vecino, Maria Cecilia Aragon; Nakamura, Yuri; Chihara, Norio; Skromne, Eli; Kopchak, Oksana; MSBase Study Investigators, missing
Source: MULTIPLE SCLEROSIS JOURNAL ; ISSN: 1352-4585 ; ISSN: 1477-0970
Publication Year: 2025
Collection: Ghent University Academic Bibliography
Subject Terms: Medicine and Health Sciences; Multiple sclerosis; neuromyelitis optica spectrum disorder; pregnancy; disease-modifying therapy; neonatal outcomes; MULTIPLE-SCLEROSIS
Description: Background: Family planning is an important aspect of multiple sclerosis (MS), and neuromyelitis optica spectrum disorder (NMOSD) management. Knowledge gaps remain, including optimal perinatal management strategies, and fetal risks associated with disease-modifying therapy (DMT) exposure.Objective: To describe perinatal DMT use, together with pregnancy and neonatal outcomes prospectively recorded in the International MSBase Pregnancy and Women's Health Registry.Methods: We report summary statistics for data collected between May 2020 and August 2024.Results: A total of 1887 relapsing-remitting MS (RRMS), 12 primary-progressive MS (PPMS), 2 radiologically isolated syndrome (RIS) and 21 NMOSD completed pregnancies were recorded, including 1644 (85.5%) live births, 208 (10.8%) miscarriages, and 6 (0.3%) neonatal deaths. Most women had unassisted (53.8%) or assisted (7.4%) vaginal births. Seventy five percent of pregnancies had DMT exposures within 6 months preconception; 19% of NMOSD, and 62% of MS pregnancies were DMT-exposed during gestation; 18.1% of pregnancies reported in-pregnancy monoclonal antibody DMT exposure. No overt safety signals were seen.Conclusion: This first report from the newly launched MSBase pregnancy registry, establishes an increasing number of pregnancies being conceived on monoclonal antibody therapies. Although no safety signals were observed, it is important to continue monitoring for safety signals in real-world databases as the use of highly effective therapies continues to increase perinatally.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://biblio.ugent.be/publication/01KEER9413343BRP34Q65VJDG6; https://doi.org/10.1177/13524585251349125; https://biblio.ugent.be/publication/01KEER9413343BRP34Q65VJDG6/file/01KEERB1PCH7CZ1NG6M588R19R
DOI: 10.1177/13524585251349125
Availability: https://biblio.ugent.be/publication/01KEER9413343BRP34Q65VJDG6; https://hdl.handle.net/1854/LU-01KEER9413343BRP34Q65VJDG6; https://doi.org/10.1177/13524585251349125; https://biblio.ugent.be/publication/01KEER9413343BRP34Q65VJDG6/file/01KEERB1PCH7CZ1NG6M588R19R
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.1AC7A89E
Database: BASE